L A Sumerel

Characterization of a messenger RNA polynucleotide vaccine vector.

R M Conry, Albert F. LoBuglio, M. Wright et al. · PubMed · 1995 · 334 citations

Vaccination, Cea Expression, Cancer Immunosurveillance +15

Efficient oncolysis by a replicating adenovirus (ad) in vivo is critically dependent on tumor expression of primary ad receptors.

Joanne T. Douglas, M Kim, L A Sumerel et al. · PubMed · 2001 · 159 citations

Replicating Adenovirus, Tumor Biology, Replicating Ad +15

The therapeutic efficacy of adenoviral vectors for cancer gene therapy is limited by a low level of primary adenovirus receptors on tumour cells

M Kim, Kurt R. Zinn, Brian Barnett et al. · European Journal of Cancer · 2002 · 135 citations

Immunology, Cancer Gene Therapy, Adenoviral Vectors +8

Immune response to a carcinoembryonic antigen polynucleotide vaccine.

R M Conry, Albert F. LoBuglio, Judy Kantor et al. · PubMed · 1994 · 123 citations

Vaccination, Cancer Immunosurveillance, Allergy +14

A carcinoembryonic antigen polynucleotide vaccine has in vivo antitumor activity.

Robert M. Conry, Albert F. LoBuglio, Frosty Loechel et al. · PubMed · 1995 · 118 citations